189 related articles for article (PubMed ID: 6738575)
1. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
Röthig HJ; Bernhardt W; Afting EG
Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
[TBL] [Abstract][Full Text] [Related]
2. Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.
Afting EG; Bernhardt W; Janzen RW; Röthig HJ
Biochem J; 1981 Nov; 200(2):449-52. PubMed ID: 7340846
[TBL] [Abstract][Full Text] [Related]
3. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
Warnes DM; Tomas FM; Ballard FJ
Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
[TBL] [Abstract][Full Text] [Related]
4. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.
Neuhäuser M; Bässler KH
Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion.
Tomas FM; Ballard FJ; Pope LM
Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219
[TBL] [Abstract][Full Text] [Related]
6. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
László A; Klujber L
Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
[TBL] [Abstract][Full Text] [Related]
7. Myofibrillar protein turnover and urinary N-tau-methylhistidine output. Response to dietary supply of protein and energy.
Haverberg LN; Deckelbaum L; Bilmazes C; Munro HN; Young VR
Biochem J; 1975 Dec; 152(3):503-10. PubMed ID: 1227503
[TBL] [Abstract][Full Text] [Related]
8. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
[TBL] [Abstract][Full Text] [Related]
9. N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition.
Holbrook IB; Gross E; Milewski PJ; Shipley K; Irving MH
Clin Sci (Lond); 1980 Sep; 59(3):211-4. PubMed ID: 6775857
[TBL] [Abstract][Full Text] [Related]
10. Sequential urinary N tau-methylhistidine to creatinine ratios in premature infants.
Burgoyne JL; Fitzgerald A; Dahlenburg GW; Haslam RR; Tomas FM; Ballard FJ
Muscle Nerve; 1986 Jan; 9(1):24-9. PubMed ID: 3951478
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios.
Sjölin J; Stjernström H; Henneberg S; Hambraeus L; Friman G
Am J Clin Nutr; 1989 Jan; 49(1):62-70. PubMed ID: 2912013
[TBL] [Abstract][Full Text] [Related]
12. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
Ballard FJ; Tomas FM; Stern LM
Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
[TBL] [Abstract][Full Text] [Related]
13. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine.
Shoji S
J Neurol Sci; 1989 Nov; 93(2-3):333-40. PubMed ID: 2592991
[TBL] [Abstract][Full Text] [Related]
14. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
Rennie MJ; Millward DJ
Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
[No Abstract] [Full Text] [Related]
15. Quantitative determination of urinary N-tau-methylhistidine output as an index of myofibrillar protein degradation.
Nagasawa T; Funabiki R
J Biochem; 1981 Apr; 89(4):1155-61. PubMed ID: 6894750
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M; Carter A; Bacon S; Winearls CG; Smith R
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
[TBL] [Abstract][Full Text] [Related]
17. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
McKeran RO; Halliday D; Purkiss P; Royston P
J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
[TBL] [Abstract][Full Text] [Related]
18. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
19. Muscle protein turnover in cattle of differing genetic backgrounds as measured by urinary N tau-methylhistidine excretion.
McCarthy FD; Bergen WG; Hawkins DR
J Nutr; 1983 Dec; 113(12):2455-63. PubMed ID: 6655509
[TBL] [Abstract][Full Text] [Related]
20. Muscle protein breakdown in thyrotoxicosis assessed by urinary 3-methylhistidine excretion.
Yates RO; Connor H; Woods HF
Ann Nutr Metab; 1981; 25(4):262-7. PubMed ID: 7305291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
